Su et al. first reported that the continuous activation of the NF-κB signaling pathway in CAFs can promote IL-6 and IL-8 expression in breast cancer and lung cancer patients, which plays a pivotal role in maintaining the stemness of cancer stem cells, leading to chemotherapy resistance5. This evidence concerns the gene NFKB1 and cancer.